Manufacturing better cell therapies

Our Research

The Shy Lab employs cutting-edge genome and epigenome engineering techniques to develop, manufacture, and deliver advanced cell and gene therapies. Our research focuses on developing novel cellular engineering tools, increasing the safety and effectiveness of cellular products, refining manufacturing processes, and incorporating emerging delivery methods. We apply these technologies to develop better treatments for a wide variety of indications including inherited immune disorders, infectious disease, and cancer. These efforts feed directly into our pre-clinical development and GMP manufacturing pipeline to make next generation therapies rapidly available for our patients.